Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Rogers

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|August 27, 2017
Abstinence-Only-Until-Marriage: An Updated Review of U.S. Policies and Programs and Their ImpactJohn S Santelli, Leslie M Kantor, Stephanie A Grilo, et al.
BMC Primary Care|January 3, 2024
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchersKevin G Pollock, Carissa Dickerson, Manjit Kainth, et al.
Journal of Medical Economics|July 14, 2022
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in EnglandNathan R Hill, Lara Groves, Carissa Dickerson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 28, 2026
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)Malinda Itchins, Marliese Alexander, Steven Kao, et al.
Contemporary Clinical Trials|October 22, 2020
Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trialNathan R Hill, Chris Arden, Lee Beresford-Hulme, et al.
European Heart Journal. Digital Health|January 30, 2023
Identification of undiagnosed atrial fibrillation using a machine learning risk-prediction algorithm and diagnostic testing (PULsE-AI) in primary care: a multi-centre randomized controlled trial in EnglandNathan R Hill, Lara Groves, Carissa Dickerson, et al.
Eclinicalmedicine|July 3, 2023
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencingStefania Oliva, Elisa Genuardi, Laura Paris, et al.
The Western Journal of Emergency Medicine|November 5, 2025
Multicenter Study Evaluating Impact of Patient and Sonographer Demographics on Quality of Focused Cardiac UltrasoundsBarret Zimmerman, Tracy E Madsen, Giorgina Giampaolo, et al.
Blood Cancer Journal|June 7, 2024
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cellsMattia D'Agostino, Delia Rota-Scalabrini, Angelo Belotti, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|August 27, 2017
Abstinence-Only-Until-Marriage: An Updated Review of U.S. Policies and Programs and Their ImpactJohn S Santelli, Leslie M Kantor, Stephanie A Grilo, et al.
BMC Primary Care|January 3, 2024
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchersKevin G Pollock, Carissa Dickerson, Manjit Kainth, et al.
Journal of Medical Economics|July 14, 2022
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in EnglandNathan R Hill, Lara Groves, Carissa Dickerson, et al.
Lung Cancer (Amsterdam, Netherlands)|June 28, 2026
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)Malinda Itchins, Marliese Alexander, Steven Kao, et al.
Contemporary Clinical Trials|October 22, 2020
Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trialNathan R Hill, Chris Arden, Lee Beresford-Hulme, et al.
European Heart Journal. Digital Health|January 30, 2023
Identification of undiagnosed atrial fibrillation using a machine learning risk-prediction algorithm and diagnostic testing (PULsE-AI) in primary care: a multi-centre randomized controlled trial in EnglandNathan R Hill, Lara Groves, Carissa Dickerson, et al.
Eclinicalmedicine|July 3, 2023
Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencingStefania Oliva, Elisa Genuardi, Laura Paris, et al.
The Western Journal of Emergency Medicine|November 5, 2025
Multicenter Study Evaluating Impact of Patient and Sonographer Demographics on Quality of Focused Cardiac UltrasoundsBarret Zimmerman, Tracy E Madsen, Giorgina Giampaolo, et al.
Blood Cancer Journal|June 7, 2024
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cellsMattia D'Agostino, Delia Rota-Scalabrini, Angelo Belotti, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Pageof 6